Pioneering system provides induction sealing integrity analysis for 100% of bottles without packaging line slowdown.
DIR Technologies, a provider of quality and process control solutions for pharmaceutical primary packaging, is showcasing its pioneering application of thermal imaging solutions for induction and heat sealing integrity assurance at ACHEMA.
The company’s Induction Integrity Verification System (I2VS) provides induction sealing integrity analysis for 100% of bottles without packaging line slowdown. Inspection is performed through the closed cap, without physical contact in an entirely passive, non–destructive fashion. DIR Technologies believes that the infrared technology has the potential to cause an industry-wide paradigm change, because it renders obsolete conventional inspection techniques that rely on destructive, imperfect, and often line-slowing sampling.
DIR Technologies also has developed the Sachet Full Monitoring System (SFM) to provide 100% in-line inspection of sachets and pouches. Both DIR systems are either in use or in trials on packaging lines for several pharmaceutical packaging companies.
The I²VS and SFM systems also provide real-time quality-control solutions that improve overall production workflow. When either system detects a potential problem, the operator is notified of the possible source of the defect, enabling any issues to be fixed promptly. In addition to a smoother manufacturing process with minimal line stoppage for workbacks, a dual benefit is that operators gain insight into a line’s intricacies that would not have been revealed through conventional sampling techniques.
Source: DIR Technologies, Hall 3.0, Stand J49
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.